Orthofix International (OFIX) Tops Q3 EPS by 7c; Trims Guidance Range

Orthofix International (NASDAQ: OFIX) reported Q3 EPS of $0.13, $0.07 better than the analyst estimate of $0.06. Revenue for the quarter came in at $114 million versus the consensus estimate of $120.68 million.

GUIDANCE:

Orthofix International sees FY2022 EPS of $0.40-$0.55, versus prior guidance of $0.45-$0.55 and the consensus of $0.40. Orthofix International sees FY2022 revenue of $457-463 million, versus prior guidance of $455-465 million and the consensus of $461.5 million.

For earnings history and earnings-related data on Orthofix International (OFIX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery